Pleiotropic Effects of Immune Responses Explain Variation in the Prevalence of Fibroproliferative Diseases

1. Wynn TA, Ramalingam TR (2012) Mechanisms of fibrosis: therapeutic translation for fibrotic disease. Nat Med 18: 1028–1040. doi: 10.1038/nm.2807 22772564

2. Balloch EA (1893) Relative frequency of fibroid processes in the dark skinned races. News XLVI: 29–35.

3. Rosser C (1925) Rectal pathology in the Negro. J Am Med Assoc LXXXIV: 93–97.

4. Rosser C (1923) Proctologic peculiarities of the Negro: the fibroplastic diathesis.Am J Surg 37: 265.

5. Moehlig RC (1937) The mesoderm of the negro. Amer J of Phys Anthropol XXII: 297–314.

6. Polednak AP (1974) Connective tissue responses in Negroes in relation to disease. Am J Phys Anthropol 41: 49–57. 4601999

7. Polednak AP (1987) Connective tissue responses in blacks in relation to disease: further observations. Am J Phys Anthropol 74: 357–371. 3322033

8. Polednak AP (1989) Various chronic disorders and other conditions. Racial and Ethnic Differences in Disease. New York: Oxford University press. pp. 228–229, 246–247.

9. Niessen FB, Spauwen PH, Schalkwijk J, Kon M (1999) On the nature of hypertrophic scars and keloids: a review. Plast Reconstr Surg 104: 1435–1458. 10513931

10. Racette L, Wilson MR, Zangwill LM, Weinreb RN, Sample PA (2003) Primary open-angle glaucoma in blacks: a review. Surv Ophthalmol 48: 295–313. 12745004

11. Morris DA, Peracha MO, Shin DH, Kim C, Cha SC, et al. (1999) Risk factors for early filtration failure requiring suture release after primary glaucoma triple procedure with adjunctive mitomycin. Arch Ophthalmol 117: 1149–1154. 10496386

12. Dustan HP (1992) Growth factors and racial differences in severity of hypertension and renal diseases. Lancet 339: 1339–1340. 1350001

13. Suthanthiran M, Li B, Song JO, Ding R, Sharma VK, et al. (2000) Transforming growth factor-beta 1 hyperexpression in African-American hypertensives: A novel mediator of hypertension and/or target organ damage. Proc Natl Acad Sci U S A 97: 3479–3484. 10725360

14. August P, Suthanthiran M (2003) Transforming growth factor beta and progression of renal disease. Kidney Int Suppl: S99–104. 14531781

15. Mayes MD, Lacey JV Jr., Beebe-Dimmer J, Gillespie BW, Cooper B, et al. (2003) Prevalence, incidence, survival, and disease characteristics of systemic sclerosis in a large US population. Arthritis Rheum 48: 2246–2255. 12905479

16. Rybicki BA, Maliarik MJ, Major M, Popovich J Jr., Iannuzzi MC (1998) Epidemiology, demographics, and genetics of sarcoidosis. Semin Respir Infect 13: 166–173. 9764947

17. Flake GP, Andersen J, Dixon D (2003) Etiology and pathogenesis of uterine leiomyomas: a review. Environ Health Perspect 111: 1037–1054. 12826476

18. Nickel R, Beck LA, Stellato C, Schleimer RP (1999) Chemokines and allergic disease. J Allergy Clin Immunol 104: 723–742. 10518815

19. Barnes KC, Grant AV, Hansel NN, Gao P, Dunston GM (2007) African Americans with asthma: genetic insights. Proc Am Thorac Soc 4: 58–68. 17202293

20. Newth CJ, Meert KL, Clark AE, Moler FW, Zuppa AF, et al. (2012) Fatal and Near-Fatal Asthma in Children: The Critical Care Perspective. J Pediatr 161: 214–221.e3. doi: 10.1016/j.jpeds.2012.02.041 22494876

21. Lester LA, Rich SS, Blumenthal MN, Togias A, Murphy S, et al. (2001) Ethnic differences in asthma and associated phenotypes: collaborative study on the genetics of asthma. J Allergy Clin Immunol 108: 357–362. 11544453

22. Prisant LM, Loebl DH, Mulloy LL (2003) Scleroderma renal crisis. J Clin Hypertens (Greenwich) 5: 168–170, 176.

23. Swigris JJ, Olson AL, Huie TJ, Fernandez-Perez ER, Solomon J, et al. (2011) Sarcoidosis-related mortality in the United States from 1988 to 2007. Am J Respir Crit Care Med 183: 1524–1530. doi: 10.1164/rccm.201010-1679OC 21330454

24. Arrindell S, Russell SB (2009) Genetics of Skin Diseases. In: Kelly PA, Taylor SC, editors. Dermatology for Skin of Color: McGraw Hill. pp. 96–104.

25. Smith JC, Boone BE, Opalenik SR, Williams SM, Russell SB (2008) Gene profiling of keloid fibroblasts shows altered expression in multiple fibrosis-associated pathways. J Invest Dermatol 128: 1298–1310. 17989729

26. Dustan HP (1995) Does keloid pathogenesis hold the key to understanding black/white differences in hypertension severity? Hypertension 26: 858–862. 7490140

27. Freedman BI, Morrow MA, Tuttle AB, Igwemezie BM, Rich SS, et al. (1998) Keloids and end-stage renal disease. Nephron 80: 244–246. 9736834

28. Shriver MD, Stroup B, and Thompson P. (1997) Genetic factors common to keloids and hypertension. Am J Hum Gen 61: A321.

29. August P, Leventhal B, Suthanthiran M (2000) Hypertension-induced organ damage in African Americans: transforming growth factor-beta(1) excess as a mechanism for increased prevalence. Curr Hypertens Rep 2: 184–191. 10981147

30. Mosmann TR, Cherwinski H, Bond MW, Giedlin MA, Coffman RL (1986) Two types of murine helper T cell clone. I. Definition according to profiles of lymphokine activities and secreted proteins. J Immunol 136: 2348–2357. 2419430

31. Wynn TA, Cheever AW, Jankovic D, Poindexter RW, Caspar P, et al. (1995) An IL-12-based vaccination method for preventing fibrosis induced by schistosome infection. Nature 376: 594–596. 7637808

32. Shi Z, Wakil AE, Rockey DC (1997) Strain-specific differences in mouse hepatic wound healing are mediated by divergent T helper cytokine responses. Proc Natl Acad Sci U S A 94: 10663–10668. 9380692

33. Reiner SL, Locksley RM (1995) The regulation of immunity to Leishmania major. Annu Rev Immunol 13: 151–177. 7612219

34. Hoffmann KF, James SL, Cheever AW, Wynn TA (1999) Studies with double cytokine-deficient mice reveal that highly polarized Th1- and Th2-type cytokine and antibody responses contribute equally to vaccine-induced immunity to Schistosoma mansoni. J Immunol 163: 927–938. 10395689

35. Hoffmann KF, McCarty TC, Segal DH, Chiaramonte M, Hesse M, et al. (2001) Disease fingerprinting with cDNA microarrays reveals distinct gene expression profiles in lethal type 1 and type 2 cytokine-mediated inflammatory reactions. Faseb J 15: 2545–2547. 11641263

36. Sandler NG, Mentink-Kane MM, Cheever AW, Wynn TA (2003) Global gene expression profiles during acute pathogen-induced pulmonary inflammation reveal divergent roles for Th1 and Th2 responses in tissue repair. J Immunol 171: 3655–3667. 14500663

37. Wynn TA (2004) Fibrotic disease and the T(H)1/T(H)2 paradigm. Nat Rev Immunol 4: 583–594. 15286725

38. Sime PJ, O'Reilly KM (2001) Fibrosis of the lung and other tissues: new concepts in pathogenesis and treatment. Clin Immunol 99: 308–319. 11358425

39. Postlethwaite AE, Holness MA, Katai H, Raghow R (1992) Human fibroblasts synthesize elevated levels of extracellular matrix proteins in response to interleukin 4. J Clin Invest 90: 1479–1485. 1401080

40. Oriente A, Fedarko NS, Pacocha SE, Huang SK, Lichtenstein LM, et al. (2000) Interleukin-13 modulates collagen homeostasis in human skin and keloid fibroblasts. J Pharmacol Exp Ther 292: 988–994. 10688614

41. Atamas SP, White B (2003) Cytokine regulation of pulmonary fibrosis in scleroderma. Cytokine Growth Factor Rev 14: 537–550. 14563355

42. Kaufman J, Sime PJ, Phipps RP (2004) Expression of CD154 (CD40 ligand) by human lung fibroblasts: differential regulation by IFN-gamma and IL-13, and implications for fibrosis. J Immunol 172: 1862–1871. 14734771

43. Jinnin M, Ihn H, Yamane K, Tamaki K (2004) Interleukin-13 stimulates the transcription of the human alpha2(I) collagen gene in human dermal fibroblasts. J Biol Chem 279: 41783–41791. 15271999

44. Shao DD, Suresh R, Vakil V, Gomer RH, Pilling D (2008) Pivotal Advance: Th-1 cytokines inhibit, and Th-2 cytokines promote fibrocyte differentiation. J Leukoc Biol 83: 1323–1333. doi: 10.1189/jlb.1107782 18332234

45. Murray LA, Argentieri RL, Farrell FX, Bracht M, Sheng H, et al. (2008) Hyper-responsiveness of IPF/UIP fibroblasts: interplay between TGFbeta1, IL-13 and CCL2. Int J Biochem Cell Biol 40: 2174–2182. doi: 10.1016/j.biocel.2008.02.016 18395486

46. Park SW, Ahn MH, Jang HK, Jang AS, Kim DJ, et al. (2009) Interleukin-13 and its receptors in idiopathic interstitial pneumonia: clinical implications for lung function. J Korean Med Sci 24: 614–620. doi: 10.3346/jkms.2009.24.4.614 19654941

47. de Jesus AR, Magalhaes A, Miranda DG, Miranda RG, Araujo MI, et al. (2004) Association of type 2 cytokines with hepatic fibrosis in human Schistosoma mansoni infection. Infect Immun 72: 3391–3397. 15155645

48. Weng HL, Liu Y, Chen JL, Huang T, Xu LJ, et al. (2009) The etiology of liver damage imparts cytokines transforming growth factor beta1 or interleukin-13 as driving forces in fibrogenesis. Hepatology 50: 230–243. doi: 10.1002/hep.22934 19441105

49. McCauley RL, Chopra V, Li YY, Herndon DN, Robson MC (1992) Altered cytokine production in black patients with keloids. J Clin Immunol 12: 300–308. 1512303

50. Diehl S, Rincon M (2002) The two faces of IL-6 on Th1/Th2 differentiation. Mol Immunol 39: 531–536. 12431386

51. Smith CJ, Smith JC, Finn MC (1987) The possible role of mast cells (allergy) in the production of keloid and hypertrophic scarring. J Burn Care Rehabil 8: 126–131. 3647037

52. Yamada H, Tajima S, Nishikawa T, Murad S, Pinnell SR (1994) Tranilast, a selective inhibitor of collagen synthesis in human skin fibroblasts. J Biochem (Tokyo) 116: 892–897.

53. Suzawa H, Ichikawa K, Kikuchi S, Yamada K, Tsuchiya O, et al. (1992) [Effect of tranilast, an anti-allergic drug, on carrageenin-induced granulation and capillary permeability in rats]. Nippon Yakurigaku Zasshi 99: 241–246. 1376712

54. Placik OJ, Lewis VL Jr. (1992) Immunologic associations of keloids. Surg Gynecol Obstet 175: 185–193. 1636146

55. Mavalia C, Scaletti C, Romagnani P, Carossino AM, Pignone A, et al. (1997) Type 2 helper T-cell predominance and high CD30 expression in systemic sclerosis. Am J Pathol 151: 1751–1758. 9403725

56. Salmon-Ehr V, Serpier H, Nawrocki B, Gillery P, Clavel C, et al. (1996) Expression of interleukin-4 in scleroderma skin specimens and scleroderma fibroblast cultures. Potential role in fibrosis. Arch Dermatol 132: 802–806. 8678573

57. Chiaramonte MG, Mentink-Kane M, Jacobson BA, Cheever AW, Whitters MJ, et al. (2003) Regulation and function of the interleukin 13 receptor alpha 2 during a T helper cell type 2-dominant immune response. J Exp Med 197: 687–701. 12642601

58. Mentink-Kane MM, Cheever AW, Thompson RW, Hari DM, Kabatereine NB, et al. (2004) IL-13 receptor alpha 2 down-modulates granulomatous inflammation and prolongs host survival in schistosomiasis. Proc Natl Acad Sci U S A 101: 586–590. 14699044

59. Granel B, Allanore Y, Chevillard C, Arnaud V, Marquet S, et al. (2006) IL13RA2 gene polymorphisms are associated with systemic sclerosis. J Rheumatol 33: 2015–2019. 16981293

60. Hotez PJ, Brindley PJ, Bethony JM, King CH, Pearce EJ, et al. (2008) Helminth infections: the great neglected tropical diseases. J Clin Invest 118: 1311–1321. doi: 10.1172/JCI34261 18382743

61. Diaz A, Allen JE (2007) Mapping immune response profiles: the emerging scenario from helminth immunology. Eur J Immunol 37: 3319–3326. 18000958

62. Allen JE, Maizels RM (2011) Diversity and dialogue in immunity to helminths. Nat Rev Immunol 11: 375–388. doi: 10.1038/nri2992 21610741

63. Fumagalli M, Pozzoli U, Cagliani R, Comi GP, Bresolin N, et al. (2010) The landscape of human genes involved in the immune response to parasitic worms. BMC Evol Biol 10: 264. doi: 10.1186/1471-2148-10-264 20807397

64. Allen JE, Wynn TA (2011) Evolution of Th2 immunity: a rapid repair response to tissue destructive pathogens. PLoS Pathog 7: e1002003. doi: 10.1371/journal.ppat.1002003 21589896

65. Smits HH, Everts B, Hartgers FC, Yazdanbakhsh M (2010) Chronic helminth infections protect against allergic diseases by active regulatory processes. Curr Allergy Asthma Rep 10: 3–12. doi: 10.1007/s11882-009-0085-3 20425508

66. Walsh KP, Brady MT, Finlay CM, Boon L, Mills KH (2009) Infection with a helminth parasite attenuates autoimmunity through TGF-beta-mediated suppression of Th17 and Th1 responses. J Immunol 183: 1577–1586. doi: 10.4049/jimmunol.0803803 19587018

67. Hartmann W, Haben I, Fleischer B, Breloer M (2011) Pathogenic nematodes suppress humoral responses to third-party antigens in vivo by IL-10-mediated interference with Th cell function. J Immunol 187: 4088–4099. doi: 10.4049/jimmunol.1004136 21900178

68. Hoffmann KF, Cheever AW, Wynn TA (2000) IL-10 and the dangers of immune polarization: excessive type 1 and type 2 cytokine responses induce distinct forms of lethal immunopathology in murine schistosomiasis. J Immunol 164: 6406–6416. 10843696

69. Yazdanbakhsh M, Kremsner PG, van Ree R (2002) Allergy, parasites, and the hygiene hypothesis. Science 296: 490–494. 11964470

70. Quinnell RJ (2003) Genetics of susceptibility to human helminth infection. Int J Parasitol 33: 1219–1231. 13678637

71. Maizels RM, Yazdanbakhsh M (2003) Immune regulation by helminth parasites: cellular and molecular mechanisms. Nat Rev Immunol 3: 733–744. 12949497

72. Le Souef PN, Goldblatt J, Lynch NR (2000) Evolutionary adaptation of inflammatory immune responses in human beings. Lancet 356: 242–244. 10963213

73. Elliott DE, Weinstock JV Helminth-host immunological interactions: prevention and control of immune-mediated diseases. Ann N Y Acad Sci 1247: 83–96. doi: 10.1111/j.1749-6632.2011.06292.x 22239614

74. Maizels RM, Yazdanbakhsh M (2008) T-cell regulation in helminth parasite infections: implications for inflammatory diseases. Chem Immunol Allergy 94: 112–123. doi: 10.1159/000154944 18802342

75. Flohr C, Quinnell RJ, Britton J (2009) Do helminth parasites protect against atopy and allergic disease? Clin Exp Allergy 39: 20–32. doi: 10.1111/j.1365-2222.2008.03134.x 19128351

76. Masters S, Barrett-Connor E (1985) Parasites and asthma—predictive or protective? Epidemiol Rev 7: 49–58. 4054238

77. Gold DR, Wright R (2005) Population disparities in asthma. Annu Rev Public Health 26: 89–113. 15760282

78. Nelson DA, Johnson CC, Divine GW, Strauchman C, Joseph CL, et al. (1997) Ethnic differences in the prevalence of asthma in middle class children. Ann Allergy Asthma Immunol 78: 21–26. 9012615

79. Grundbacher FJ, Massie FS (1985) Levels of immunoglobulin G, M, A, and E at various ages in allergic and nonallergic black and white individuals. J Allergy Clin Immunol 75: 651–658. 4008794

80. Vergara C, Murray T, Rafaels N, Lewis R, Campbell M, et al. (2013) African ancestry is a risk factor for asthma and high total IgE levels in African admixed populations. Genet Epidemiol 37: 393–401. doi: 10.1002/gepi.21702 23554133

81. D'Elia R, Behnke JM, Bradley JE, Else KJ (2009) Regulatory T cells: a role in the control of helminth-driven intestinal pathology and worm survival. J Immunol 182: 2340–2348. doi: 10.4049/jimmunol.0802767 19201888

82. Hopkin J (2009) Immune and genetic aspects of asthma, allergy and parasitic worm infections: evolutionary links. Parasite Immunol 31: 267–273. doi: 10.1111/j.1365-3024.2009.01104.x 19388947

83. Barnes KC, Grant AV, Gao P (2005) A review of the genetic epidemiology of resistance to parasitic disease and atopic asthma: common variants for common phenotypes? Curr Opin Allergy Clin Immunol 5: 379–385. 16131910

84. Moller M, Gravenor MB, Roberts SE, Sun D, Gao P, et al. (2007) Genetic haplotypes of Th-2 immune signalling link allergy to enhanced protection to parasitic worms. Hum Mol Genet 16: 1828–1836. 17519224

85. Holgate ST (2012) Innate and adaptive immune responses in asthma. Nat Med 18: 673–683. doi: 10.1038/nm.2731 22561831

86. Shifren A, Witt C, Christie C, Castro M (2012) Mechanisms of remodeling in asthmatic airways. J Allergy (Cairo) 2012: 316049.

87. Smillie WG, Augustine DL (1925) Intensity of hookworm infestation in Alabama. Its relationship to residence, occupation, age, sex and race. J Am Med Assoc 85: 1958–1963.

88. Keller AE, Leather WS, Knox JC,. (1937) The present status of hookworm infestation in North Carolina. Am J Hyg 26: 437–454.

89. Coelho PRP, McGuire RA (2006) Racial differences in disease susceptibilities: intestinal worm infection in the early twentieth-century American south. Soc Hist Med 19: 461–482.

90. Williams-Blangero S, Subedi J, Upadhayay RP, Manral DB, Rai DR, et al. (1999) Genetic analysis of susceptibility to infection with Ascaris lumbricoides. Am J Trop Med Hyg 60: 921–926. 10403321

91. Abel L, Demenais F, Prata A, Souza AE, Dessein A (1991) Evidence for the segregation of a major gene in human susceptibility/resistance to infection by Schistosoma mansoni. Am J Hum Genet 48: 959–970. 1902058

92. Marquet S, Abel L, Hillaire D, Dessein H, Kalil J, et al. (1996) Genetic localization of a locus controlling the intensity of infection by Schistosoma mansoni on chromosome 5q31-q33. Nat Genet 14: 181–184. 8841190

93. Muller-Myhsok B, Stelma FF, Guisse-Sow F, Muntau B, Thye T, et al. (1997) Further evidence suggesting the presence of a locus, on human chromosome 5q31-q33, influencing the intensity of infection with Schistosoma mansoni. Am J Hum Genet 61: 452–454. 9311752

94. Kouriba B, Chevillard C, Bream JH, Argiro L, Dessein H, et al. (2005) Analysis of the 5q31-q33 locus shows an association between IL13-1055C/T IL-13-591A/G polymorphisms and Schistosoma haematobium infections. J Immunol 174: 6274–6281. 15879126

95. Cameron L, Webster RB, Strempel JM, Kiesler P, Kabesch M, et al. (2006) Th2 cell-selective enhancement of human IL13 transcription by IL13-1112C>T, a polymorphism associated with allergic inflammation. J Immunol 177: 8633–8642. 17142763

96. van der Pouw Kraan TC, van Veen A, Boeije LC, van Tuyl SA, de Groot ER, et al. (1999) An IL-13 promoter polymorphism associated with increased risk of allergic asthma. Genes Immun 1: 61–65. 11197307

97. Gatlin MR, Black CL, Mwinzi PN, Secor WE, Karanja DM, et al. (2009) Association of the gene polymorphisms IFN-gamma +874, IL-13–1055 and IL-4–590 with patterns of reinfection with Schistosoma mansoni. PLoS Negl Trop Dis 3: e375. doi: 10.1371/journal.pntd.0000375 19190772

98. He H, Isnard A, Kouriba B, Cabantous S, Dessein A, et al. (2008) A STAT6 gene polymorphism is associated with high infection levels in urinary schistosomiasis. Genes Immun 9: 195–206. doi: 10.1038/gene.2008.2 18273035

99. Bethony JM, Quinnell RJ (2008) Genetic epidemiology of human schistosomiasis in Brazil. Acta Trop 108: 166–174. doi: 10.1016/j.actatropica.2007.11.008 18207118

100. Prata A (1992) Influence of the host related factors in the development of the hepatosplenic form of schistosomiasis mansoni. Mem Inst Oswaldo Cruz 87 Suppl 4: 39–44. 1343924

101. Bina JC, Tavares-Neto J, Prata A, Azevedo ES (1978) Greater resistance to the development of severe schistosomiasis in Brazilian negroes. Hum Biol 50: 41–49. 649103

102. Mwatha JK, Kimani G, Kamau T, Mbugua GG, Ouma JH, et al. (1998) High levels of TNF, soluble TNF receptors, soluble ICAM-1, and IFN-gamma, but low levels of IL-5, are associated with hepatosplenic disease in human schistosomiasis mansoni. J Immunol 160: 1992–1999. 9469463

103. Mbow M, Larkin BM, Meurs L, Wammes LJ, de Jong SE, et al. (2013) T-helper 17 cells are associated with pathology in human schistosomiasis. J Infect Dis 207: 186–195. doi: 10.1093/infdis/jis654 23087431

104. Rutitzky LI, Stadecker MJ (2011) Exacerbated egg-induced immunopathology in murine Schistosoma mansoni infection is primarily mediated by IL-17 and restrained by IFN-gamma. Eur J Immunol 41: 2677–2687. doi: 10.1002/eji.201041327 21660933

105. Abath FG, Morais CN, Montenegro CE, Wynn TA, Montenegro SM (2006) Immunopathogenic mechanisms in schistosomiasis: what can be learnt from human studies? Trends Parasitol 22: 85–91. 16380294

106. Chevillard C, Moukoko CE, Elwali NE, Bream JH, Kouriba B, et al. (2003) IFN-gamma polymorphisms (IFN-gamma +2109 and IFN-gamma +3810) are associated with severe hepatic fibrosis in human hepatic schistosomiasis (Schistosoma mansoni). J Immunol 171: 5596–5601. 14607968

107. Henri S, Chevillard C, Mergani A, Paris P, Gaudart J, et al. (2002) Cytokine regulation of periportal fibrosis in humans infected with Schistosoma mansoni: IFN-gamma is associated with protection against fibrosis and TNF-alpha with aggravation of disease. J Immunol 169: 929–936. 12097398

108. Dessein AJ, Hillaire D, Elwali NE, Marquet S, Mohamed-Ali Q, et al. (1999) Severe hepatic fibrosis in Schistosoma mansoni infection is controlled by a major locus that is closely linked to the interferon-gamma receptor gene. Am J Hum Genet 65: 709–721. 10441577

109. Wilfing A, Winkler S, Schrattbauer K, Willheim M, Baier K, et al. (2001) African-European differences in the capacity of T-cell cytokine production. Am J Trop Med Hyg 65: 504–509. 11716105

110. Abecasis GR, Auton A, Brooks LD, DePristo MA, Durbin RM, et al. (2012) An integrated map of genetic variation from 1,092 human genomes. Nature 491: 56–65. doi: 10.1038/nature11632 23128226

111. Altshuler DM, Gibbs RA, Peltonen L, Altshuler DM, Gibbs RA, et al. (2010) Integrating common and rare genetic variation in diverse human populations. Nature 467: 52–58. doi: 10.1038/nature09298 20811451

112. Basehore MJ, Howard TD, Lange LA, Moore WC, Hawkins GA, et al. (2004) A comprehensive evaluation of IL4 variants in ethnically diverse populations: association of total serum IgE levels and asthma in white subjects. J Allergy Clin Immunol 114: 80–87. 15241348

113. Nie W, Zhu Z, Pan X, Xiu Q (2013) The interleukin-4 -589C/T polymorphism and the risk of asthma: a meta-analysis including 7,345 cases and 7,819 controls. Gene 520: 22–29. doi: 10.1016/j.gene.2013.02.027 23454622

114. Burchard EG, Silverman EK, Rosenwasser LJ, Borish L, Yandava C, et al. (1999) Association between a sequence variant in the IL-4 gene promoter and FEV(1) in asthma. Am J Respir Crit Care Med 160: 919–922. 10471619

115. Donfack J, Schneider DH, Tan Z, Kurz T, Dubchak I, et al. (2005) Variation in conserved non-coding sequences on chromosome 5q and susceptibility to asthma and atopy. Respir Res 6: 145. 16336695

116. Haller G, Torgerson DG, Ober C, Thompson EE (2009) Sequencing the IL4 locus in African Americans implicates rare noncoding variants in asthma susceptibility. J Allergy Clin Immunol 124: 1204–1209 e1209. doi: 10.1016/j.jaci.2009.09.013 19910025

117. Rockman MV, Hahn MW, Soranzo N, Goldstein DB, Wray GA (2003) Positive selection on a human-specific transcription factor binding site regulating IL4 expression. Curr Biol 13: 2118–2123. 14654003

118. Rosenwasser LJ, Borish L (1997) Genetics of atopy and asthma: the rationale behind promoter-based candidate gene studies (IL-4 and IL-10). Am J Respir Crit Care Med 156: S152–155. 9351597

119. Akkad DA, Arning L, Ibrahim SM, Epplen JT (2007) Sex specifically associated promoter polymorphism in multiple sclerosis affects interleukin 4 expression levels. Genes Immun 8: 703–706. 17855802

120. Heinzmann A, Mao XQ, Akaiwa M, Kreomer RT, Gao PS, et al. (2000) Genetic variants of IL-13 signalling and human asthma and atopy. Hum Mol Genet 9: 549–559. 10699178

121. Hummelshoj T, Bodtger U, Datta P, Malling HJ, Oturai A, et al. (2003) Association between an interleukin-13 promoter polymorphism and atopy. Eur J Immunogenet 30: 355–359. 14641544

122. Doucet C, Brouty-Boye D, Pottin-Clemenceau C, Canonica GW, Jasmin C, et al. (1998) Interleukin (IL) 4 and IL-13 act on human lung fibroblasts. Implication in asthma. J Clin Invest 101: 2129–2139. 9593769

123. Hershey GK (2003) IL-13 receptors and signaling pathways: an evolving web. J Allergy Clin Immunol 111: 677–690; quiz 691. 12704343

124. Wilson MS, Elnekave E, Mentink-Kane MM, Hodges MG, Pesce JT, et al. (2007) IL-13Ralpha2 and IL-10 coordinately suppress airway inflammation, airway-hyperreactivity, and fibrosis in mice. J Clin Invest 117: 2941–2951. 17885690

125. Granel B, Chevillard C, Allanore Y, Arnaud V, Cabantous S, et al. (2006) Evaluation of interleukin 13 polymorphisms in systemic sclerosis. Immunogenetics 58: 693–699. 16832637

126. Isnard A, Kouriba B, Doumbo O, Chevillard C (2011) Association of rs7719175, located in the IL13 gene promoter, with Schistosoma haematobium infection levels and identification of a susceptibility haplotype. Genes Immun 12: 31–39. doi: 10.1038/gene.2010.43 20861864

127. Chatila TA (1998) Genetics of atopic diseases. Curr Opin Pediatr 10: 584–587. 9848017

128. Deichmann K, Bardutzky J, Forster J, Heinzmann A, Kuehr J (1997) Common polymorphisms in the coding part of the IL4-receptor gene. Biochem Biophys Res Commun 231: 696–697. 9070874

129. Hackstein H, Hecker M, Kruse S, Bohnert A, Ober C, et al. (2001) A novel polymorphism in the 5' promoter region of the human interleukin-4 receptor alpha-chain gene is associated with decreased soluble interleukin-4 receptor protein levels. Immunogenetics 53: 264–269. 11491529

130. Bergin AM, Balder B, Kishore S, Sward K, Hahn-Zoric M, et al. (2006) Common variations in the IL4R gene affect splicing and influence natural expression of the soluble isoform. Hum Mutat 27: 990–998. 16917945

131. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA (1997) The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 337: 1720–1725. 9392697

132. Rosa-Rosa L, Zimmermann N, Bernstein JA, Rothenberg ME, Khurana Hershey GK (1999) The R576 IL-4 receptor alpha allele correlates with asthma severity. J Allergy Clin Immunol 104: 1008–1014. 10550746

133. Mitsuyasu H, Yanagihara Y, Mao XQ, Gao PS, Arinobu Y, et al. (1999) Cutting edge: dominant effect of Ile50Val variant of the human IL-4 receptor alpha-chain in IgE synthesis. J Immunol 162: 1227–1231. 9973373

134. Wjst M, Kruse S, Illig T, Deichmann K (2002) Asthma and IL-4 receptor alpha gene variants. Eur J Immunogenet 29: 263–268. 12047364

135. Kruse S, Japha T, Tedner M, Sparholt SH, Forster J, et al. (1999) The polymorphisms S503P and Q576R in the interleukin-4 receptor alpha gene are associated with atopy and influence the signal transduction. Immunology 96: 365–371. 10233717

136. Wu X, Di Rienzo A, Ober C (2001) A population genetics study of single nucleotide polymorphisms in the interleukin 4 receptor alpha (IL4RA) gene. Genes Immun 2: 128–134. 11426321

137. Caggana M, Walker K, Reilly AA, Conroy JM, Duva S, et al. (1999) Population-based studies reveal differences in the allelic frequencies of two functionally significant human interleukin-4 receptor polymorphisms in several ethnic groups. Genet Med 1: 267–271. 11258628

138. Ober C, Leavitt SA, Tsalenko A, Howard TD, Hoki DM, et al. (2000) Variation in the interleukin 4-receptor alpha gene confers susceptibility to asthma and atopy in ethnically diverse populations. Am J Hum Genet 66: 517–526. 10677312

139. Tachdjian R, Mathias C, Al Khatib S, Bryce PJ, Kim HS, et al. (2009) Pathogenicity of a disease-associated human IL-4 receptor allele in experimental asthma. J Exp Med 206: 2191–2204. doi: 10.1084/jem.20091480 19770271

140. Youn J, Hwang SH, Cho CS, Min JK, Kim WU, et al. (2000) Association of the interleukin-4 receptor alpha variant Q576R with Th1/Th2 imbalance in connective tissue disease. Immunogenetics 51: 743–746. 10941846

141. Battle NC, Choudhry S, Tsai HJ, Eng C, Kumar G, et al. (2007) Ethnicity-specific gene-gene interaction between IL-13 and IL-4Ralpha among African Americans with asthma. Am J Respir Crit Care Med 175: 881–887. 17303794

142. Couper KN, Blount DG, Riley EM (2008) IL-10: the master regulator of immunity to infection. J Immunol 180: 5771–5777. 18424693

143. Peranteau WH, Zhang L, Muvarak N, Badillo AT, Radu A, et al. (2008) IL-10 overexpression decreases inflammatory mediators and promotes regenerative healing in an adult model of scar formation. J Invest Dermatol 128: 1852–1860. doi: 10.1038/sj.jid.5701232 18200061

144. Booth M, Mwatha JK, Joseph S, Jones FM, Kadzo H, et al. (2004) Periportal fibrosis in human Schistosoma mansoni infection is associated with low IL-10, low IFN-gamma, high TNF-alpha, or low RANTES, depending on age and gender. J Immunol 172: 1295–1303. 14707108

145. Grant AV, Araujo MI, Ponte EV, Oliveira RR, Cruz AA, et al. (2011) Polymorphisms in IL10 are associated with total Immunoglobulin E levels and Schistosoma mansoni infection intensity in a Brazilian population. Genes Immun 12: 46–50. doi: 10.1038/gene.2010.50 20927126

146. Hayden CM, Zhang G, Judge PK, Khoo SK, Laing IA, et al. (2011) Regulatory role of IL10 genetic variations in determining allergen-induced T(H)2 cytokine responses in children. J Allergy Clin Immunol 128: 237–239 e238. doi: 10.1016/j.jaci.2011.02.032 21439624

147. Silva PC, Gomes AV, de Souza TK, Coelho MR, Cahu GG, et al. (2014) Association of SNP (-G1082A) IL-10 with Increase in Severity of Periportal Fibrosis in Schistosomiasis, in the Northeast of Brazil. Genet Test Mol Biomarkers 18: 646–52. doi: 10.1089/gtmb.2014.0098 25079344

148. Hoffmann SC, Stanley EM, Cox ED, DiMercurio BS, Koziol DE, et al. (2002) Ethnicity greatly influences cytokine gene polymorphism distribution. Am J Transplant 2: 560–567. 12118901

149. Smith AJ, Humphries SE (2009) Cytokine and cytokine receptor gene polymorphisms and their functionality. Cytokine Growth Factor Rev 20: 43–59. doi: 10.1016/j.cytogfr.2008.11.006 19038572

150. Delaney NL, Esquenazi V, Lucas DP, Zachary AA, Leffell MS (2004) TNF-alpha, TGF-beta, IL-10, IL-6, and INF-gamma alleles among African Americans and Cuban Americans. Report of the ASHI Minority Workshops: Part IV. Hum Immunol 65: 1413–1419. 15603866

151. Ihn H (2002) Pathogenesis of fibrosis: role of TGF-beta and CTGF. Curr Opin Rheumatol 14: 681–685. 12410091

152. Border WA, Noble NA (1994) Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286–1292. 7935686

153. Drumm ML, Konstan MW, Schluchter MD, Handler A, Pace R, et al. (2005) Genetic modifiers of lung disease in cystic fibrosis. N Engl J Med 353: 1443–1453. 16207846

154. Phillips JA 3rd, Poling JS, Phillips CA, Stanton KC, Austin ED, et al. (2008) Synergistic heterozygosity for TGFbeta1 SNPs and BMPR2 mutations modulates the age at diagnosis and penetrance of familial pulmonary arterial hypertension. Genet Med 10: 359–365. doi: 10.1097/GIM.0b013e318172dcdf 18496036

155. Eiser AR (2010) Does over-expression of transforming growth factor-beta account for the increased morbidity in African-Americans: Possible clinical study and therapeutic implications. Medical Hypotheses 75: 418–421. doi: 10.1016/j.mehy.2010.04.009 20457494

156. August P, Sharma V, Ding R, Schwartz JE, Suthanthiran M (2009) Transforming growth factor beta and excess burden of renal disease. Trans Am Clin Climatol Assoc 120: 61–72. 19768163

157. Shah R, Rahaman B, Hurley CK, Posch PE (2006) Allelic diversity in the TGFB1 regulatory region: characterization of novel functional single nucleotide polymorphisms. Hum Genet 119: 61–74. 16369764

158. Oldroyd SD, Thomas GL, Gabbiani G, El Nahas AM (1999) Interferon-gamma inhibits experimental renal fibrosis. Kidney Int 56: 2116–2127. 10594787

159. Giri SN, Hyde DM, Marafino BJ Jr. (1986) Ameliorating effect of murine interferon gamma on bleomycin-induced lung collagen fibrosis in mice. Biochem Med Metab Biol 36: 194–197. 2430600

160. Pravica V, Asderakis A, Perrey C, Hajeer A, Sinnott PJ, et al. (1999) In vitro production of IFN-gamma correlates with CA repeat polymorphism in the human IFN-gamma gene. Eur J Immunogenet 26: 1–3. 10068907

161. Hassan MI, Aschner Y, Manning CH, Xu J, Aschner JL (2003) Racial differences in selected cytokine allelic and genotypic frequencies among healthy, pregnant women in North Carolina. Cytokine 21: 10–16. 12668154

162. Upperman JS, Pillage G, Siddiqi MQ, Zeevi A, Kelly N, et al. (2005) Dominance of high-producing interleukin 6 and low-producing interleukin 10 and interferon gamma alleles in glucose-6-phosphate dehydrogenase-deficient trauma patients. Shock 23: 197–201. 15718915

163. Rosenzweig SD, Schaffer AA, Ding L, Sullivan R, Enyedi B, et al. (2004) Interferon-gamma receptor 1 promoter polymorphisms: population distribution and functional implications. Clin Immunol 112: 113–119. 15207788

164. Gao PS, Mao XQ, Jouanguy E, Pallier A, Doffinger R, et al. (1999) Nonpathogenic common variants of IFNGR1 and IFNGR2 in association with total serum IgE levels. Biochem Biophys Res Commun 263: 425–429. 10491309

165. Ferguson JF, Patel PN, Shah RY, Mulvey CK, Gadi R, et al. (2013) Race and gender variation in response to evoked inflammation. J Transl Med 11: 63. doi: 10.1186/1479-5876-11-63 23497455

166. Lyn-Cook BD, Xie C, Oates J, Treadwell E, Word B, et al. (2014) Increased expression of Toll-like receptors (TLRs) 7 and 9 and other cytokines in systemic lupus erythematosus (SLE) patients: ethnic differences and potential new targets for therapeutic drugs. Mol Immunol 61: 38–43. doi: 10.1016/j.molimm.2014.05.001 24865418

167. Ye CJ, Feng T, Kwon HK, Raj T, Wilson MT, et al. (2014) Intersection of population variation and autoimmunity genetics in human T cell activation. Science 345: 1254665. doi: 10.1126/science.1254665 25214635

168. Lustigman S, Prichard RK, Gazzinelli A, Grant WN, Boatin BA, et al. (2012) A research agenda for helminth diseases of humans: the problem of helminthiases. PLoS Negl Trop Dis 6: e1582. doi: 10.1371/journal.pntd.0001582 22545164

169. Weir BS, Cockerham C (1984) Estimating F-statistics for the analysis of population structure. Evolution 38: 1358–1370.

170. Tielsch JM, Sommer A, Katz J, Royall RM, Quigley HA, et al. (1991) Racial variations in the prevalence of primary open-angle glaucoma. The Baltimore Eye Survey. JAMA 266: 369–374. 2056646

171. (2005) Racial/ethnic disparities in prevalence, treatment, and control of hypertension—United States, 1999–2002. MMWR Morb Mortal Wkly Rep 54: 7–9.

172. Barrett J (1973) Keloid. In: Bergsma D, editor. Birth Defect Compendium. Baltimore: Williams and Wilkens Company. pp. 553.

173. Drazner MH, Dries DL, Peshock RM, Cooper RS, Klassen C, et al. (2005) Left ventricular hypertrophy is more prevalent in blacks than whites in the general population: the Dallas Heart Study. Hypertension 46: 124–129. 15939807

174. Kizer JR, Arnett DK, Bella JN, Paranicas M, Rao DC, et al. (2004) Differences in left ventricular structure between black and white hypertensive adults: the Hypertension Genetic Epidemiology Network study. Hypertension 43: 1182–1188. 15123573

175. Lackland DT, Keil J.E (1996) Epidemiology of hypertension in African Americans. Semin Nephrol 16: 63–70. 8668862

176. Ferguson R, Grim CE, Opgenorth TJ (1987) The epidemiology of end-state renal disease: the six-year South-Central Los Angeles experience, 1980–85. Am J Public Health 77: 864–865. 3592045

177. Tracy RE, Bhandaru SY, Oalmann MC, Guzman MA, Newmann WP 3rd (1991) Blood pressure and nephrosclerosis in black and white men and women aged 25 to 54. Mod Pathol 4: 602–609. 1758872

178. Freedman BI, Bowden DW, Rich SS, Valis CJ, Sale MM, et al. (2005) A genome scan for all-cause end-stage renal disease in African Americans. Nephrol Dial Transplant 20: 712–718. 15701670

179. (USRDS) URDS (1998) 1998 Annual Data Report. Bethesda, MD: The National Institutes of Health, National Institute of Diabetes Digestive, and Kidney Diseases.

180. System URD (2003) USRDS 2003 Annual Data Report: Atlas of End-Stage Renal Disease in the United States. Bethesda, MD: National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases.

181. Toto RB (2003) Hypertensive nephrosclerosis in African Americans. Kidney Int 64: 2331–2341. 14633170

182. Terris M, Chaves AD (1966) An epidemiologic study of sarcoidosis. Am Rev Respir Dis 94: 50–55. 5945340

183. Keller AZ (1971) Hospital, age, racial, occupational, geographical, clinical and survivorship characteristics in the epidemiology of sarcoidosis. Am J Epidemiol 94: 222–230. 5093653

184. Sartwell PE, Edwards LB (1974) Epidemiology of sarcoidosis in the U.S. Navy. Am J Epidemiol 99: 250–257. 4818715

185. Rybicki BA, Harrington D, Major M, Simoff M, Popovich J Jr., et al. (1996) Heterogeneity of familial risk in sarcoidosis. Genet Epidemiol 13: 23–33. 8647376

186. Rybicki BA, Major M, Popovich J Jr., Maliarik MJ, Iannuzzi MC (1997) Racial differences in sarcoidosis incidence: a 5-year study in a health maintenance organization. Am J Epidemiol 145: 234–241. 9012596

187. Kucera GP, Rybicki BA, Kirkey KL, Coon SW, Major ML, et al. (2003) Occupational risk factors for sarcoidosis in African-American siblings. Chest 123: 1527–1535. 12740270

188. Iannuzzi MC, Rybicki BA, Teirstein AS (2007) Sarcoidosis. N Engl J Med 357: 2153–2165. 18032765

189. Masi AT, D'Angelo WA (1967) Epidemiology of fatal systemic sclerosis (diffuse scleroderma). A 15-year survey in Baltimore. Ann Intern Med 66: 870–883. 6025228

190. Arnett FC, Cho M, Chatterjee S, Aguilar MB, Reveille JD, et al. (2001) Familial occurrence frequencies and relative risks for systemic sclerosis (scleroderma) in three United States cohorts. Arthritis Rheum 44: 1359–1362. 11407695

191. Mayes MD (2003) Scleroderma epidemiology. Rheum Dis Clin North Am 29: 239–254. 12841293

192. Siegel M, Holley HL, Lee SL (1970) Epidemiologic studies on systemic lupus erythematosus. Comparative data for New York City and Jefferson County, Alabama, 1956–1965. Arthritis Rheum 13: 802–811. 5495391

193. Wilson WA, Hughes GR (1979) Rheumatic disease in Jamaica. Ann Rheum Dis 38: 320–325. 315207

194. Hochberg MC (1997) The epidemiology of systemic lupus erythematosus. In: Wallace DJ, Hahn B.H., Quismorio F.P., editor. Dubois' lupus erythematosus. Baltimore: Williams and Wilkins. pp. 49–65.

195. Rus VHA (2001) Systemic lupus erythematosus. In: Silman AJHM, editor. Epidemiology of rheumatic diseases: Oxford University Press. pp. 123–140.

196. Marshall LM, Spiegelman D, Barbieri RL, Goldman MB, Manson JE, et al. (1997) Variation in the incidence of uterine leiomyoma among premenopausal women by age and race. Obstet Gynecol 90: 967–973. 9397113

197. Christopherson WM, Nealon NA (1981) Uterine cancer: a comparative study of black and white women. Prog Clin Biol Res 53: 185–195. 7465586

198. Day Baird D, Dunson DB, Hill MC, Cousins D, Schectman JM (2003) High cumulative incidence of uterine leiomyoma in black and white women: ultrasound evidence. Am J Obstet Gynecol 188: 100–107. 12548202

199. Yu Q, Horak K, Larson DF (2006) Role of T lymphocytes in hypertension-induced cardiac extracellular matrix remodeling. Hypertension 48: 98–104. 16735642

200. Peng H, Yang XP, Carretero OA, Nakagawa P, D'Ambrosio M, et al. (2011) Angiotensin II-induced dilated cardiomyopathy in Balb/c but not C57BL/6J mice. Exp Physiol 96: 756–764. doi: 10.1113/expphysiol.2011.057612 21602297

201. DeMeo DL, Lange C, Silverman EK, Senter JM, Drazen JM, et al. (2002) Univariate and multivariate family-based association analysis of the IL-13 ARG130GLN polymorphism in the Childhood Asthma Management Program. Genet Epidemiol 23: 335–348. 12432502

202. Grant AV, Araujo MI, Ponte EV, Oliveira RR, Gao P, et al. (2012) Functional polymorphisms in IL13 are protective against high Schistosoma mansoni infection intensity in a Brazilian population. PLoS One 7: e35863. doi: 10.1371/journal.pone.0035863 22574126

203. Shah R, Hurley CK, Posch PE (2006) A molecular mechanism for the differential regulation of TGF-beta1 expression due to the common SNP -509C-T (c. -1347C > T). Hum Genet 120: 461–469. 16896927

204. Grainger DJ, Heathcote K, Chiano M, Snieder H, Kemp PR, et al. (1999) Genetic control of the circulating concentration of transforming growth factor type beta1. Hum Mol Genet 8: 93–97. 9887336

205. Silverman ES, Palmer LJ, Subramaniam V, Hallock A, Mathew S, et al. (2004) Transforming growth factor-beta1 promoter polymorphism C-509T is associated with asthma. Am J Respir Crit Care Med 169: 214–219. 14597484

206. Awad M, Pravica V, Perrey C, El Gamel A, Yonan N, et al. (1999) CA repeat allele polymorphism in the first intron of the human interferon-gamma gene is associated with lung allograft fibrosis. Hum Immunol 60: 343–346. 10363726